Related Experiment Video
Updated: Jan 9, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
Emergence, function, and therapeutic strategies to target the PD-1/PD-L1 immune checkpoint during pathogenic fungal
Xiaofang Zheng1,2, Xuemei He1, Zhangyong Song1,2,3
1School of Basic Medical Sciences, Southwest Medical University, LuZhou, China.
Abstract:
Human pathogenic fungi are ubiquitous in the environment and induce an expanding repertoire of devastating diseases globally. Upon fungal invasion, the fungus adopts multiple strategies to adapt to, or eliminate, hostile environmental conditions, which immune checkpoints serve as one of the mechanism for fungal evasion. Programmed death receptor-1 (PD-1), an immunosuppressive molecule, transmits inhibitory signals upon binding to its ligand PD-L1. During infection, aberrant activation of the PD-1/PD-L1 pathway has been proven to facilitate immune evasion by the pathogen. In this review, we summarize the roles of PD-1/PD-L1 in fungal infection. First, the molecular structures and function of PD-1 and PD-L1 are described. Then, we highlight the dynamic expression patterns and regulatory mechanisms of PD-1/PD-L1 during fungal invasion. Potential therapeutics based on PD-1/PD-L1-blocking to enhance antifungal immunity and improve clinical outcomes are also discussed. These insights reveal future directions regarding PD-1/PD-L1 and immune checkpoint-based therapies for preventing pathogenic fungi infections.
Insights
Pathogenic fungi evade immune responses by exploiting the PD-1/PD-L1 pathway. Blocking this immune checkpoint may enhance antifungal immunity and improve treatment outcomes for fungal infections.
Area of Science:
- Immunology
- Mycology
- Pathogen-host interactions
Background:
- Human pathogenic fungi cause widespread, severe diseases globally.
- Fungi employ immune evasion strategies, including the manipulation of immune checkpoints.
- The programmed death receptor-1 (PD-1) and its ligand PD-L1 pathway are key immunosuppressive mechanisms.
Purpose of the Study:
- To review the role of the PD-1/PD-L1 pathway in fungal infections.
- To describe the molecular aspects and functions of PD-1 and PD-L1.
- To discuss therapeutic strategies targeting PD-1/PD-L1 for antifungal immunity.
Main Methods:
- Literature review summarizing current research on PD-1/PD-L1 in fungal infections.
- Analysis of molecular structures and functions of PD-1 and PD-L1.
- Discussion of expression patterns, regulation, and therapeutic potential.
Main Results:
- Aberrant activation of the PD-1/PD-L1 pathway aids pathogen immune evasion during infection.
- Dynamic expression and regulation of PD-1/PD-L1 are observed during fungal invasion.
- PD-1/PD-L1-blocking strategies show potential for enhancing antifungal immunity.
Conclusions:
- The PD-1/PD-L1 pathway is a critical target for fungal immune evasion.
- Targeting PD-1/PD-L1 offers a promising therapeutic avenue for fungal infections.
- Further research into PD-1/PD-L1 and immune checkpoint inhibitors is warranted for antifungal therapies.
Related Concept Videos
Fungal Phylum Microsporidia
Tumor Immunotherapy
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

